Works matching IS 13889842 AND DT 2020 AND VI 22 AND IP 11
Results: 34
Corrigendum to 'Departments involved during the first episode of acute heart failure and analysis of emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort' [Eur J Heart Fail 2019;21:1231-1244].
- Published in:
- 2020
- Publication type:
- corrected article
Figures of the Heart Failure Association: Prof. Lars H. Lund, Chair of the HFA Committee on Registries, Surveys and Epidemiology and HFA Board Member (from 2016).
- Published in:
- 2020
- By:
- Publication type:
- Biography
Effects of hyperkalaemia and non-adherence to renin-angiotensin-aldosterone system inhibitor therapy in patients with heart failure in Italy: a propensity-matched study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Myocardial iron content in non‐ischaemic cardiomyopathy: how much is known?
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2047, doi. 10.1002/ejhf.2023
- By:
- Publication type:
- Article
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
- Published in:
- 2020
- By:
- Publication type:
- journal article
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2160, doi. 10.1002/ejhf.2015
- By:
- Publication type:
- Article
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure (an update on the sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Learning together: insights from the first Heart Failure Association patient forum.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1939, doi. 10.1002/ejhf.2013
- By:
- Publication type:
- Article
Ten lessons from the EMPEROR‐Reduced trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1991, doi. 10.1002/ejhf.2009
- By:
- Publication type:
- Article
EMPEROR-Reduced: confirming sodium-glucose co-transporter 2 inhibitors as an essential treatment for patients with heart failure with reduced ejection fraction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sex‐based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2018, doi. 10.1002/ejhf.2005
- By:
- Publication type:
- Article
Beating the bushes for biomarkers.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2075, doi. 10.1002/ejhf.2004
- By:
- Publication type:
- Article
Cancer therapy and the heart; the necessity to calibrate risk.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1961, doi. 10.1002/ejhf.1999
- By:
- Publication type:
- Article
A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is Dickkopf‐3 (DKK3) a possible candidate?
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2065, doi. 10.1002/ejhf.1988
- By:
- Publication type:
- Article
Serum potassium in the PARADIGM‐HF trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2056, doi. 10.1002/ejhf.1987
- By:
- Publication type:
- Article
Serum uric acid, influence of sacubitril–valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2093, doi. 10.1002/ejhf.1984
- By:
- Publication type:
- Article
DAPA‐HF: does dapagliflozin provide 'bang for your buck' as a treatment for heart failure with reduced ejection fraction?
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2157, doi. 10.1002/ejhf.1982
- By:
- Publication type:
- Article
In search of a 'safety zone' for glycaemic control: association between glycosylated haemoglobin levels and outcomes in patients with type 2 diabetes and cardiovascular disease.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2035, doi. 10.1002/ejhf.1981
- By:
- Publication type:
- Article
Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2147, doi. 10.1002/ejhf.1978
- By:
- Publication type:
- Article
Frailty and the failing heart do not travel alone.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2120, doi. 10.1002/ejhf.1973
- By:
- Publication type:
- Article
Pathogenesis and management of myocardial injury in coronavirus disease 2019.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1994, doi. 10.1002/ejhf.1967
- By:
- Publication type:
- Article
Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE‐HF cohort study.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2112, doi. 10.1002/ejhf.1926
- By:
- Publication type:
- Article
Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2026, doi. 10.1002/ejhf.1958
- By:
- Publication type:
- Article
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1945, doi. 10.1002/ejhf.1920
- By:
- Publication type:
- Article
Assessing frailty in heart failure.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2134, doi. 10.1002/ejhf.1905
- By:
- Publication type:
- Article
<sup>18</sup> F-FDG PET/CT brain glucose metabolism as a marker of different types of depression comorbidity in chronic heart failure patients with impaired systolic function.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Depression and heart failure: the lonely comorbidity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Age and biomarkers in heart failure: challenging the current model to select patients for clinical trials.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2078, doi. 10.1002/ejhf.1701
- By:
- Publication type:
- Article
The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2102, doi. 10.1002/ejhf.1674
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. i, doi. 10.1002/ejhf.1962
- Publication type:
- Article
November 2020 at a glance: focus on comorbidities and medical treatment.
- Published in:
- 2020
- By:
- Publication type:
- journal article